ADALIMUMAB
Clinical Indication
Behcet’s disease
Comments
Alternative to infliximab once established on therapy.
Subcutaneous preparation able to be administered at home.
Date of classification
September 2015
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.